Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a large decline in short interest in May. As of May 29th, there was short interest totaling 69 shares, a decline of 90.6% from the May 14th total of 734 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 2,285 shares, the short-interest ratio is presently 0.0 days.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Several hedge funds and other institutional investors have recently modified their holdings of the business. Osaic Holdings Inc. grew its position in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after acquiring an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC lifted its stake in shares of Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the period. Finally, Susquehanna International Group LLP boosted its stake in Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after acquiring an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Trading Down 1.4%

NYSEARCA BOUT traded down $0.63 during midday trading on Wednesday, hitting $45.12. The company had a trading volume of 2,890 shares, compared to its average volume of 4,535. The company has a market capitalization of $15.79 million, a PE ratio of 28.69 and a beta of 1.04. The firm has a 50-day moving average price of $44.42 and a 200-day moving average price of $40.56. Innovator IBD Breakout Opportunities ETF has a twelve month low of $35.05 and a twelve month high of $48.05.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.